F. Meacci

575 total citations
19 papers, 354 citations indexed

About

F. Meacci is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, F. Meacci has authored 19 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in F. Meacci's work include Breast Cancer Treatment Studies (6 papers), Lung Cancer Treatments and Mutations (4 papers) and BRCA gene mutations in cancer (3 papers). F. Meacci is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Lung Cancer Treatments and Mutations (4 papers) and BRCA gene mutations in cancer (3 papers). F. Meacci collaborates with scholars based in Italy, United States and Malaysia. F. Meacci's co-authors include Lorenzo Livi, Icro Meattini, Daniela Greto, Pierluigi Bonomo, Monica Mangoni, Gabriele Simontacchi, Beatrice Detti, Lucia Di Brina, Silvia Scoccianti and C. Talamonti and has published in prestigious journals such as European Journal of Cancer, Radiotherapy and Oncology and Neuro-Oncology.

In The Last Decade

F. Meacci

19 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Meacci Italy 7 145 109 97 93 86 19 354
J.A. Hattangadi United States 12 212 1.5× 128 1.2× 124 1.3× 101 1.1× 88 1.0× 31 496
Salvatore Cozzi Italy 14 216 1.5× 65 0.6× 113 1.2× 112 1.2× 67 0.8× 46 422
Alessandra Mirri Italy 9 159 1.1× 65 0.6× 65 0.7× 76 0.8× 111 1.3× 15 307
Jason C. Ye United States 9 126 0.9× 73 0.7× 49 0.5× 122 1.3× 61 0.7× 28 317
K.P. Haresh India 12 152 1.0× 43 0.4× 51 0.5× 47 0.5× 122 1.4× 56 372
Minh Thi Tieu Australia 10 50 0.3× 118 1.1× 60 0.6× 86 0.9× 70 0.8× 16 345
Chan Woo Wee South Korea 13 152 1.0× 42 0.4× 47 0.5× 89 1.0× 170 2.0× 55 398
Daniele Scartoni Italy 9 212 1.5× 44 0.4× 82 0.8× 76 0.8× 48 0.6× 45 351
Allen G. Meek United States 6 134 0.9× 78 0.7× 62 0.6× 125 1.3× 64 0.7× 8 323
Mauro Arcicasa Italy 12 135 0.9× 68 0.6× 26 0.3× 93 1.0× 109 1.3× 28 318

Countries citing papers authored by F. Meacci

Since Specialization
Citations

This map shows the geographic impact of F. Meacci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Meacci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Meacci more than expected).

Fields of papers citing papers by F. Meacci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Meacci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Meacci. The network helps show where F. Meacci may publish in the future.

Co-authorship network of co-authors of F. Meacci

This figure shows the co-authorship network connecting the top 25 collaborators of F. Meacci. A scholar is included among the top collaborators of F. Meacci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Meacci. F. Meacci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Esposito, M., Pietro Mancosu, S. Pini, et al.. (2023). The role of EPID in vivo dosimetry in the risk management of stereotactic lung treatments. Strahlentherapie und Onkologie. 199(11). 992–999. 1 indexed citations
2.
Perrone, Fabiana, Lorenzo Belluomini, Marco Mazzotta, et al.. (2021). Exploring the role of respiratory microbiome in lung cancer: A systematic review. Critical Reviews in Oncology/Hematology. 164. 103404–103404. 24 indexed citations
3.
Borghetti, Paolo, Marco Lorenzo Bonù, Niccolò Giaj‐Levra, et al.. (2019). Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group. La radiologia medica. 124(7). 662–670. 32 indexed citations
4.
Scotti, Vieri, Marco Perna, F. Meacci, et al.. (2019). A rare case of non-small cell lung cancer choroidal metastasis responding to ALK tyrosine kinase inhibitors. Anti-Cancer Drugs. 31(1). 90–94. 2 indexed citations
5.
Meattini, Icro, Calogero Saieva, Guido Miccinesi, et al.. (2017). Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial. European Journal of Cancer. 76. 17–26. 42 indexed citations
6.
Meattini, Icro, Calogero Saieva, Guido Miccinesi, et al.. (2017). Health-related quality of life analysis from the accelerated partial breast irradiation IMRT-Florence phase 3 trial: Impact of age and scores trend over time. European Journal of Cancer. 72. S8–S8. 1 indexed citations
7.
Meattini, Icro, M. Guenzi, Alessandra Fozza, et al.. (2016). Overview on cardiac, pulmonary and cutaneous toxicity in patients treated with adjuvant radiotherapy for breast cancer. Breast Cancer. 24(1). 52–62. 33 indexed citations
8.
Meattini, Icro, Calogero Saieva, F. Meacci, et al.. (2016). Impact of Age on Cytotoxic-Induced Ovarian Failure in Breast Cancer Treated with Adjuvant Chemotherapy and Triptorelin. Future Oncology. 12(5). 625–635. 5 indexed citations
9.
Scoccianti, Silvia, Beatrice Detti, Davide Gadda, et al.. (2015). Organs at risk in the brain and their dose-constraints in adults and in children: A radiation oncologist’s guide for delineation in everyday practice. Radiotherapy and Oncology. 114(2). 230–238. 148 indexed citations
10.
Meattini, Icro, Giulio Francolini, Vieri Scotti, et al.. (2015). Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer. Medical Oncology. 32(3). 80–80. 3 indexed citations
11.
Scotti, Vieri, Icro Meattini, Ciro Franzese, et al.. (2014). Radiotherapy timing in the treatment of limited-stage small cell lung cancer: the impact of thoracic and brain irradiation on survival.. PubMed. 100(3). 289–95. 4 indexed citations
12.
Scoccianti, Silvia, Beatrice Detti, Daniela Greto, et al.. (2014). P13.21 * ORGANS AT RISK IN THE BRAIN AND THEIR DOSE-CONSTRAINTS IN THE ADULTS AND IN THE CHILDREN: A RADIATION ONCOLOGIST'S GUIDE FOR DELINEATION. Neuro-Oncology. 16(suppl 2). ii70–ii70. 1 indexed citations
13.
Scotti, Vieri, Icro Meattini, Ciro Franzese, et al.. (2014). Radiotherapy Timing in the Treatment of Limited-stage Small Cell Lung Cancer: The Impact of Thoracic and Brain Irradiation on Survival. Tumori Journal. 100(3). 289–295. 4 indexed citations
14.
Meattini, Icro, Lorenzo Livi, Davide Franceschini, et al.. (2013). Role of radiotherapy boost in women with ductal carcinoma in situ: A single-center experience in a series of 389 patients. European Journal of Surgical Oncology. 39(6). 613–618. 22 indexed citations
15.
Livi, Lorenzo, Pierluigi Bonomo, Icro Meattini, et al.. (2013). Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience. Medical Oncology. 30(1). 434–434. 6 indexed citations
16.
Livi, Lorenzo, Icro Meattini, Davide Franceschini, et al.. (2013). Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 Patients treated with a prospective margin-directed policy. Radiotherapy and Oncology. 108(2). 273–278. 19 indexed citations
17.
Meattini, Icro, Lorenzo Livi, Davide Franceschini, et al.. (2012). Treatment of invasive male breast cancer: a 40-year single-institution experience. La radiologia medica. 118(3). 476–486. 4 indexed citations
18.
Livi, Lorenzo, Icro Meattini, Calogero Saieva, et al.. (2012). OC-0131 ACCELERATED PARTIAL BREAST IRRADIATION WITH IMRT: 3-YEARS INTERIM ANALYSIS OF A PHASE III RANDOMIZED CLINICAL TRIAL. Radiotherapy and Oncology. 103. S51–S51. 2 indexed citations
19.
Livi, Lorenzo, Icro Meattini, Calogero Saieva, et al.. (2012). 467 Accelerated Partial Breast Irradiation with Intensity-modulated Radiotherapy (IMRT): the Florence Phase III Randomized Clinical Trial at 3 Years Median Follow-up. European Journal of Cancer. 48. S183–S183. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.A. Hattangadi Breakdown of academic impact, for papers by Salvatore Cozzi Breakdown of academic impact, for papers by Alessandra Mirri Breakdown of academic impact, for papers by Jason C. Ye Breakdown of academic impact, for papers by K.P. Haresh Breakdown of academic impact, for papers by Minh Thi Tieu Breakdown of academic impact, for papers by Chan Woo Wee Breakdown of academic impact, for papers by Daniele Scartoni Breakdown of academic impact, for papers by Allen G. Meek Breakdown of academic impact, for papers by Mauro Arcicasa
Rankless by CCL
2026